Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.

@article{Mao2000StructurebasedDD,
  title={Structure-based drug design of non-nucleoside inhibitors for wild-type and drug-resistant HIV reverse transcriptase.},
  author={C. Mao and E. Sudbeck and T. Venkatachalam and F. Uckun},
  journal={Biochemical pharmacology},
  year={2000},
  volume={60 9},
  pages={
          1251-65
        }
}
  • C. Mao, E. Sudbeck, +1 author F. Uckun
  • Published 2000
  • Medicine, Chemistry
  • Biochemical pharmacology
  • The generation of anti-HIV agents using structure-based drug design methods has yielded a number of promising non-nucleoside inhibitors (NNIs) of HIV reverse transcriptase (RT). Recent successes in identifying potent NNIs are reviewed with an emphasis on the recent trend of utilizing a computer model of HIV RT to identify space in the NNI binding pocket that can be exploited by carefully chosen functional groups predicted to interact favorably with binding pocket residues. The NNI binding… CONTINUE READING
    54 Citations
    Novel tight binding PETT, HEPT and DABO-based non-nucleoside inhibitors of HIV-1 reverse transcriptase
    • O. D'cruz, F. Uckun
    • Biology, Medicine
    • Journal of enzyme inhibition and medicinal chemistry
    • 2006
    • 22
    The search for potent, small molecule NNRTIs: A review.
    • 57
    Comparative study of non nucleoside inhibitors with HIV-1 reverse transcriptase based on 3D-QSAR and docking
    • 14
    • Highly Influenced
    Dawn of non-nucleoside inhibitor-based anti-HIV microbicides.
    • 96
    • PDF
    Steered molecular dynamics simulation on the binding of NNRTI to HIV-1 RT.
    • 64
    • PDF
    Theoretical studies on the molecular basis of HIV-1RT/NNRTIs interactions
    • 6
    Effect of stereochemistry on the anti-HIV activity of chiral thiourea compounds.
    • 112

    References

    SHOWING 1-10 OF 63 REFERENCES
    Structure of the binding site for nonnucleoside inhibitors of the reverse transcriptase of human immunodeficiency virus type 1.
    • S. Smerdon, J. Jaeger, +5 authors T. Steitz
    • Biology, Medicine
    • Proceedings of the National Academy of Sciences of the United States of America
    • 1994
    • 285
    • PDF
    Novel concepts in the treatment of human immunodeficiency virus type 1 (HIV-1) infections by HIV-1-specific reverse transcriptase inhibitors.
    • J. Balzarini
    • Biology, Medicine
    • Verhandelingen - Koninklijke Academie voor Geneeskunde van Belgie
    • 1995
    • 2